Article
Toll-like Receptors and Inflammatory Bowel Disease.
Frontiers in immunology - 1 Jan 2018
Lu Yue, Li Xinrui, Liu Shanshan, Zhang Yifan, Zhang Dekai
Abstract excerpt
Inflammatory bowel disease (IBD) is one relapsing and lifelong disease that affects millions of patients worldwide. Increasing evidence has recently highlighted immune-system dysfunction, especially toll-like receptors (TLRs)-mediated innate immune dysfunction, as central players in the pathogenesis of IBD. TLRs and TLR-activated signaling pathways are involved not only in the pathogenesis but also in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.